Thursday, 25 February 2021

Cipla invests in a respiratory device firm

19 February 2015 | News | By BioSpectrum Bureau

Cipla invests in a respiratory device firm

Jay Precision currently supplies respiratory devices to Cipla

Jay Precision currently supplies respiratory devices to Cipla

Cipla has announced that it will acquire 60 percent stake in Jay Precision Pharmaceuticals for Rs 96 crore, says reports.

Jay Precision is an existing supplier of respiratory devices to the company and has a manufacturing facility at Vasai, Maharashtra.

"Considering company's leading position in inhalation therapy, this transaction is aimed at integrating the value chain and will serve as a platform for the development of next generation respiratory devices," the company said in a statement.

The transaction is expected to be completed by the end of this financial year, subject to completion of certain conditions.

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account






Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls